Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Oxycodone hydrochloride/naloxone hydrochloride
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Oxycodone 10mg / Naloxone 5mg modified-release tablets
0407020AFAAAAAA
|
Oxycodone hydrochloride/naloxone hydrochloride | Oxycodone hydrochloride/naloxone hydrochloride | Central Nervous System | 1,948 |
|
Oxycodone 20mg / Naloxone 10mg modified-release tablets
0407020AFAAABAB
|
Oxycodone hydrochloride/naloxone hydrochloride | Oxycodone hydrochloride/naloxone hydrochloride | Central Nervous System | 1,522 |
|
Targinact 10mg/5mg modified-release tablets
0407020AFBBAAAA
|
Targinact | Oxycodone hydrochloride/naloxone hydrochloride | Central Nervous System | 1,355 |
|
Oxycodone 5mg / Naloxone 2.5mg modified-release tablets
0407020AFAAACAC
|
Oxycodone hydrochloride/naloxone hydrochloride | Oxycodone hydrochloride/naloxone hydrochloride | Central Nervous System | 1,206 |
|
Targinact 20mg/10mg modified-release tablets
0407020AFBBABAB
|
Targinact | Oxycodone hydrochloride/naloxone hydrochloride | Central Nervous System | 1,101 |
|
Targinact 5mg/2.5mg modified-release tablets
0407020AFBBACAC
|
Targinact | Oxycodone hydrochloride/naloxone hydrochloride | Central Nervous System | 1,020 |
|
Oxycodone 40mg / Naloxone 20mg modified-release tablets
0407020AFAAADAD
|
Oxycodone hydrochloride/naloxone hydrochloride | Oxycodone hydrochloride/naloxone hydrochloride | Central Nervous System | 532 |
|
Targinact 40mg/20mg modified-release tablets
0407020AFBBADAD
|
Targinact | Oxycodone hydrochloride/naloxone hydrochloride | Central Nervous System | 443 |
|
Myloxifin 10mg/5mg modified-release tablets
0407020AFBCAAAA
|
Myloxifin | Oxycodone hydrochloride/naloxone hydrochloride | Central Nervous System | 33 |
|
Myloxifin 20mg/10mg modified-release tablets
0407020AFBCABAB
|
Myloxifin | Oxycodone hydrochloride/naloxone hydrochloride | Central Nervous System | 21 |
|
Myloxifin 5mg/2.5mg modified-release tablets
0407020AFBCADAC
|
Myloxifin | Oxycodone hydrochloride/naloxone hydrochloride | Central Nervous System | 13 |
|
Myloxifin 40mg/20mg modified-release tablets
0407020AFBCACAD
|
Myloxifin | Oxycodone hydrochloride/naloxone hydrochloride | Central Nervous System | 11 |
|
Oxyargin 40mg/20mg modified-release tablets
0407020AFBDADAD
|
Oxyargin | Oxycodone hydrochloride/naloxone hydrochloride | Central Nervous System | 1 |
|
Oxyargin 5mg/2.5mg modified-release tablets
0407020AFBDAAAC
|
Oxyargin | Oxycodone hydrochloride/naloxone hydrochloride | Central Nervous System | 1 |
|
Sofonac 5mg/2.5mg modified-release tablets
0407020AFBEADAC
|
Sofonac | Oxycodone hydrochloride/naloxone hydrochloride | Central Nervous System | 1 |
|
Oxyargin 10mg/5mg modified-release tablets
0407020AFBDABAA
|
Oxyargin | Oxycodone hydrochloride/naloxone hydrochloride | Central Nervous System | No data available |
|
Oxyargin 20mg/10mg modified-release tablets
0407020AFBDACAB
|
Oxyargin | Oxycodone hydrochloride/naloxone hydrochloride | Central Nervous System | No data available |
|
Oxycodone 40mg/5ml / Naloxone 20mg/5ml oral suspension
0407020AFAAAEAE
|
Oxycodone hydrochloride/naloxone hydrochloride | Oxycodone hydrochloride/naloxone hydrochloride | Central Nervous System | No data available |
|
Sofonac 10mg/5mg modified-release tablets
0407020AFBEAAAA
|
Sofonac | Oxycodone hydrochloride/naloxone hydrochloride | Central Nervous System | No data available |
|
Sofonac 20mg/10mg modified-release tablets
0407020AFBEABAB
|
Sofonac | Oxycodone hydrochloride/naloxone hydrochloride | Central Nervous System | No data available |
|
Sofonac 40mg/20mg modified-release tablets
0407020AFBEACAD
|
Sofonac | Oxycodone hydrochloride/naloxone hydrochloride | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.